Abstract
Justin George Mathew, Alisa Morss Clyne
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Microvascular basement membranes in diabetes mellitus
10.1002/path.1439 · 2003
Abnormal angiogenesis in diabetes mellitus
10.1002/med.10024 · 2003
On measuring the adequacy of diabetes regulation: comparison of continuously monitored blood glucose patterns with values at selected time points
10.1007/bf01219670 · 1974
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
10.1056/nejmoa052187 · 2005
Angiogenesis
10.1146/annurev.med.57.121304.131306 · 2006
Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice
10.1007/s001250051640 · 2001
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
10.1126/science.3487117 · 1986
Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats
10.1161/01.cir.96.6.1991 · 1997
Inhibition of angiogenesis on glycated collagen lattices
10.1007/s001250050937 · 1998
Delayed branching of endothelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1
10.1152/ajprenal.2001.281.1.f71 · 2001
Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability
10.1074/jbc.m608565200 · 2007
Altered distribution of basic fibroblast growth factor in diabetic retinopathy
10.1001/archopht.1991.01080070117048 · 1991
Fibroblast growth factor-2
10.1016/s1357-2725(99)00123-5 · 2000
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
10.1161/hq0701.093685 · 2001
Plasminogen activators, tissue degradation, and cancer
10.1016/s0065-230x(08)60028-7 · 1985
One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity
10.1016/s0021-9258(18)37940-7 · 1988
Autocrine saturation of pro-urokinase receptors on human A431 cells
10.1016/0092-8674(86)90782-8 · 1986
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants
10.1016/s0021-9258(17)39071-3 · 1985
Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin
10.1016/s0021-9258(18)83353-1 · 1989
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor
10.1073/pnas.86.13.4828 · 1989
Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease
10.1016/j.coph.2005.01.007 · 2005
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects
10.1161/hq0801.093667 · 2001
Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence
10.1161/01.cir.97.22.2213 · 1998
Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor
10.1002/jcp.1041620312 · 1995
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro
10.1083/jcb.111.2.743 · 1990
Glycated collagen impairs endothelial cell response to cyclic Stretch
10.1007/s12195-011-0176-9 · 2011
Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species
10.1098/rsif.2011.0220 · 2012
Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2
10.1186/2045-824x-3-12 · 2011
Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity
10.1074/jbc.m104028200 · 2001
Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites
10.1016/0006-291x(92)91834-d · 1992
Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation
10.2337/diab.41.2.s49 · 1992
Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation
10.1006/bbrc.1997.7718 · 1997
Glycated collagen and altered glucose increase endothelial cell adhesion strength
10.1002/jcp.24313 · 2013
Altered glucose increased endothelial cell adhesion strength
10.1002/jcp.24313 · 2013
Role of plasminogen activator-plasmin system in tumor angiogenesis
10.1007/s000180300039 · 2003
Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells
10.1111/j.1538-7836.2004.00845.x · 2004
The plasminogen activation system in tumor growth, invasion, and metastasis
10.1007/s000180050497 · 2000
No additional external references are available.